The analysis of prognostic factors in stage III-B non-inflammatory breast cancer

European Journal of Surgical Oncology

Volumn 26, Issue 1, 2000, Pages 34-38

  Yildirim, E ^a   Semerci, E ^a   Berberoglu U ^a  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Prognosis

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VOLUME;

EID: 0033966451     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0737     Document Type: Article

References (33)

1. Hunt KK, Ames FC, Singletary SE, Buzdar AU, Hortobagyi GN. Locally advanced noninflammatory breast cancer. Surg Clin North Am. 76:1996;393-410.
2. Harris, J, Morrow, M, Norton, L, In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer. Principles and Practice of Oncology (5th edn). Philadelphia, 1997, 1599, 601.
3. Swain SM, Sorace RA, Bagley CS et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res. 47:1987;3889-3894.
4. Hortobagyi GN, Ames FC, Buzdar AK et al. Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer. 62:1988;2507-2516.
5. Bonadonna G, Veronesi U, Brambilla C et al. Primary chemotherapy to avoid mastectomy in tumours with diameters of three centimeters or more. J Natl Cancer Inst. 82:1990;1539-1545.
6. Booser D, Frye D, Singletary S et al. Response to induction chemotherapy for breast cancer: a prospective multimodality treatment program (abstract 156). Proc Am Soc Clin Oncol. 11:1992;82.
7. Hortobagyi GN, Buzdar AU, Strom EA, Ames FC, Singletary SE. Primary chemotherapy for early and advanced breast cancer. Cancer LEtt. 90:1995;103-109.
8. Buzdar AU, Singletary SE, Booser DJ, Frye DK, Wasaff B, Horotbagyi GN. Combined modality treatment of stage III and inflammatory breast cancer. Surg Oncol Clin North Am. 4:1995;715-734.
9. Aktepe F, KapucuogÆlu N, Pak I. The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer. Histopathology. 29:1996;63-67.
10. American Cancer Society and American College of Surgeons. (5th edn). Fleming ID, Cooper JS, Henson DE, et al (eds). AJCC Cancer Staging Manual. 1997;171-178.
11. Hayward JL, Carbone PP, Henson JC et al. Assessment of response to therapy in advanced breast cancer. Eur J Cancer. 13:1977;89-94.
12. Bloom HJG, Richardson VW. Histological grading and prognosis in breast cancer. Br J Cancer. 11:1957;359-377.
13. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc. 53:1958;457-481.
14. Cox DR. Regression models and life tables. J R Stat Soc. B34:1972;187-220.
15. Swain SM. Selection of therapy for stage III breast cancer. Surg Clin North Am. 70:1990;1061-1080.
16. Boddie AW, Warso M, Briele H et al. Multimodal-therapy breast salvage in the urban poor with locally advanced cancer. Arch Surg. 131:1996;424-429.
17. Eltahir A, Heys SD, Hutcheon AW et al. Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. Am J Surg. 175:1998;127-132.
18. Sataloff DM, Mason BA, Prestipino AJ et al. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg. 180:1995;297-306.
19. Cocconi G, di Blasio B, Bisagni G et al. Neoadjuvant chemotherapy or chemotherapy and endocrine therapy in locally advanced breast carcinoma. Am J Clin Oncol. 13:1990;226-235.
20. Cummiskey RD, Mera R, Levine EA. Preoperative chemo- therapy for locally advanced breast carcinoma at Charity Hospital, New Orleans, Lousiana. Am Surg. 64:1998;103-106.
21. Lippman M, Sorace R, Bagley C et al. Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. Natl Cancer Inst Monog. 1:1986;153.
22. Schwartz G, Birchansky C, Komarnicky L et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of breast. Cancer. 73:1994;362-369.
23. Scholl S, Fourquet A, Asselain B et al. Neoadjuvant vs adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer. 30A:1994;645.
24. Gardin G, Rosso R, Campora E et al. Locally advanced nonmetastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. Eur J Cancer. 31A:1995;1428-1433.
25. Machiavelli MR, Romero AO, Perez JE et al. Prognostic significance of pathological response of primary tumour and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Cancer J Sci Am. 4:1998;125-131.
26. Perez CA, Graham ML, Taylor ME et al. Management of locally advanced carcinoma of breast. I. Noninflammatory. Cancer. 74 (Suppl. 1):1994;453-465.
27. Piccart M, De Valerola D, Paridaens R et al. Six-year results of multimodality treatment strategy for locally advanced breast cancer. Cancer. 62:1988;2501.
28. Honkoop AH, van Diest PJ, de Jong JS et al. Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer. 77:1998;621-626.
29. Fisher B, Slack N, Bross I et al. Cancer of the breast: size of neoplasm and prognosis. Cancer. 24:1969;1071.
30. Kuerer HM, Newman LA, Buzdar AU et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg. 176:1998;502-509.
31. Cocconi G, Di Blasio B, Alberti G et al. Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat. 4:1984;309.
32. Feldman L, Hortobagyi G, Buzdar A et al. Pathologic assessment of response to induction chemotherapy in breast cancer. Cancer Res. 46:1986;2578-2581.
33. McCready D, Hortobagyi G, Kau S et al. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg. 124:1989;21-25.